Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015, Article ID 758687, 5 pages
http://dx.doi.org/10.1155/2015/758687
Research Article

Elevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis

Department of Opthalmology, Faculty of Medicine, Trakya University, 22030 Edirne, Turkey

Received 20 January 2015; Revised 1 April 2015; Accepted 9 April 2015

Academic Editor: Paolo Fogagnolo

Copyright © 2015 Hande Guclu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Halilovic, I. Alimanovic, E. Suljic, and N. A. Hassan, “Optic neuritis as first clinical manifestations the multiple sclerosis,” Mater Sociomed, vol. 26, no. 4, pp. 246–248, 2014. View at Google Scholar
  2. C. N. Pedro-Egbe, B. Fiebai, and C. S. Ejimadu, “Visual outcome following optic neuritis: a 5-year review,” Nigerian Journal of Clinical Practice, vol. 15, no. 3, pp. 311–314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. W. Beck, “Optic neuritis: clinical considerations and the relationship to multiple sclerosis,” Neuroophthalmology, vol. 20, pp. 1–20, 1998. View at Google Scholar
  4. J. Siddiqui, J. Rouleau, A. G. Lee, Y. Sato, and M. D. Voigt, “Bilateral optic neuritis in acute hepatitis C,” Journal of Neuro-Ophthalmology, vol. 29, no. 2, pp. 128–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H.-S. Lee, K.-D. Choi, J.-E. Lee, and H.-K. Park, “Optic neuritis after Klebsiella pneumonitis and liver abscess,” Journal of Neuro-Ophthalmology, vol. 29, no. 2, pp. 134–135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Bojić, M. Ivanišević, A. Siničić et al., “The incidence of optic neuritis in Split-Dalmatia County, Croatia,” Collegium Antropologicum, vol. 28, no. 1, pp. 343–347, 2004. View at Google Scholar · View at Scopus
  7. M. Rodriguez, A. Siva, S. A. Cross, P. C. O'Brien, and L. T. Kurland, “Optic neuritis: a population-based study in Olmsted County, Minnesota,” Neurology, vol. 45, no. 2, pp. 244–250, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. Optic Neuritis Study Group, “The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial,” Archives of Ophthalmology, vol. 109, no. 12, pp. 1673–1678, 1991. View at Google Scholar
  9. A. K. Percy, F. T. Nobrega, and L. T. Kurland, “Optic neuritis and multiple sclerosis. An epidemiologic study,” Archives of Ophthalmology, vol. 87, no. 2, pp. 135–139, 1972. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Imtiaz, K. Shafique, S. Mirza, Z. Ayoob, P. Vart, and S. Rao, “Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population,” International Archives of Medicine, vol. 5, no. 1, article 2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. B. B. Sen, E. N. Rifaioğlu, O. Ekiz, M. U. Inan, T. Sen, and N. Sen, “Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis,” Cutaneous and Ocular Toxicology, vol. 33, no. 3, pp. 223–227, 2014. View at Publisher · View at Google Scholar
  12. C. Briggs, “Quality counts: new parameters in blood cell counting,” International Journal of Laboratory Hematology, vol. 31, no. 3, pp. 277–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. L. Grove, A.-M. Hvas, and S. D. Kristensen, “Immature platelets in patients with acute coronary syndromes,” Thrombosis and Haemostasis, vol. 101, no. 1, pp. 151–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. P. Ranjith, R. Divya, V. K. Mehta, M. G. Krishnan, R. KamalRaj, and A. Kavishwar, “Significance of platelet volume indices and platelet count in ischaemic heart disease,” Journal of Clinical Pathology, vol. 62, no. 9, pp. 830–833, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Aktas, A. Alcelik, B. K. Tekce, V. Tekelioğlu, M. Sit, and H. Savli, “Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome,” Przegląd Gastroenterologiczny, vol. 9, no. 3, pp. 160–163, 2014. View at Publisher · View at Google Scholar
  16. K. Farkas, M. Papp, T. Nyári et al., “Red blood cell distribution width in combination with serological markers can help in the differentiation between Crohn's disease and ulcerative colitis,” Open Gastroenterology Journal, vol. 4, pp. 1–4, 2010. View at Google Scholar
  17. C. S. Song, D. I. Park, M. Y. Yoon et al., “Association between red cell distribution width and disease activity in patients with inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 57, no. 4, pp. 1033–1038, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Cakal, A. G. Akoz, Y. Ustundag, M. Yalinkilic, A. Ulker, and H. Ankarali, “Red cell distribution width for assessment of activity of inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 54, no. 4, pp. 842–847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Arhan, I. K. Önal, A. Taş et al., “The role of red cell distribution width as a marker in inflammatory bowel disease,” Turkish Journal of Medical Sciences, vol. 41, no. 2, pp. 227–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. P. N. Shams and G. T. Plant, “Optic neuritis: a review,” The International MS Journal, vol. 16, no. 3, pp. 82–89, 2009. View at Google Scholar · View at Scopus
  21. S. R. Cole, R. W. Beck, P. S. Moke, R. L. Gal, and D. T. Long, “The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial,” Investigative Ophthalmology & Visual Science, vol. 41, no. 5, pp. 1017–1021, 2000. View at Google Scholar
  22. J. A. Fleishman, R. W. Beck, O. A. Linares, and J. W. Klein, “Deficits in visual function after resolution of optic neuritis,” Ophthalmology, vol. 94, no. 8, pp. 1029–1035, 1987. View at Publisher · View at Google Scholar · View at Scopus
  23. R. W. Beck, P. A. Cleary, M. M. Anderson Jr. et al., “A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis,” The New England Journal of Medicine, vol. 326, no. 9, pp. 581–588, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. R. W. Beck, P. A. Cleary, and J.-Y. C. Backlund, “The course of visual recovery after optic neuritis: experience of the optic neuritis treatment trial,” Ophthalmology, vol. 101, no. 11, pp. 1771–1778, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Tsakiri, S. Ravanidis, R. Lagoudaki et al., “Neuroprotective and anti-inflammatory mechanisms are activated early in optic neuritis,” Acta Neurologica Scandinavica, vol. 131, no. 5, pp. 305–312, 2015. View at Publisher · View at Google Scholar
  26. Optic Neuritis Study Group, “Visual function 5 years after optic neuritis,” Archives of Ophthalmology, vol. 115, pp. 1545–1552, 1997. View at Google Scholar
  27. R. W. Beck and P. A. Cleary, “Optic neuritis treatment trial: one-year follow-up results,” Archives of Ophthalmology, vol. 111, no. 6, pp. 773–775, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Du, J.-J. Li, Y.-J. Zhang, K. Li, and J.-F. He, “Risk factors for idiopathic optic neuritis recurrence,” PLoS ONE, vol. 9, no. 9, Article ID e108580, 2014. View at Publisher · View at Google Scholar
  29. The Optic Neuritis Study Group, “Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up,” Archives of Neurology, vol. 65, no. 6, pp. 727–732, 2008. View at Publisher · View at Google Scholar
  30. Y. Yang, W.-P. Wu, D.-H. Huang, and L. Wu, “Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system,” Zhonghua Yi Xue Za Zhi, vol. 92, no. 43, pp. 3032–3035, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Ilhan, M. C. Daglioglu, O. Ilhan et al., “Assessment of neutrophil/lymphocyte ratio in patients with age-related macular degeneration,” Ocular Immunology and Inflammation, vol. 2, pp. 1–4, 2014. View at Publisher · View at Google Scholar
  32. E. E. Karaca, M. C. Özmen, F. Ekici, E. Yüksel, and Z. Türkoğlu, “Neutrophil-to-lymphocyte ratio may predict progression in patients with keratoconus,” Cornea, vol. 33, no. 11, pp. 1168–1173, 2014. View at Publisher · View at Google Scholar
  33. S. M. Ulu, M. Dogan, A. Ahsen et al., “Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy,” Diabetes Technology & Therapeutics, vol. 15, no. 11, pp. 942–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. S. J. Woo, S. J. Ahn, J. Ahn, K. H. Park, and K. Lee, “Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects,” Investigative Ophthalmology and Visual Science, vol. 52, no. 10, pp. 7697–7703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. R. T. Wang, J. R. Zhang, Y. Li, T. Liu, and K. J. Yu, “Neutrophil-Lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes,” Journal of Diabetes and Its Complications, vol. 29, no. 2, pp. 245–249, 2015. View at Google Scholar
  36. A. Ataseven, A. U. Bilgin, and G. S. Kurtipek, “The importance of neutrophil lymphocyte ratio in patients with psoriasis,” Materia Socio-Medica, vol. 26, no. 4, pp. 231–233, 2014. View at Google Scholar
  37. B. Kisacik, A. Tufan, U. Kalyoncu et al., “Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis,” Joint Bone Spine, vol. 75, no. 3, pp. 291–294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. S. Ulasli, B. A. Ozyurek, E. B. Yilmaz, and G. Ulubay, “Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease,” Polskie Archiwum Medycyny Wewnetrznej, vol. 122, no. 6, pp. 284–290, 2012. View at Google Scholar · View at Scopus
  39. G. L. Salvagno, F. Sanchis-Gomar, A. Picanza, and G. Lippi, “Red blood cell distribution width: a simple parameter with multiple clinical applications,” Critical Reviews in Clinical Laboratory Sciences, vol. 23, pp. 1–20, 2014. View at Publisher · View at Google Scholar
  40. G. Lippi, G. Targher, M. Montagnana, G. L. Salvagno, G. Zoppini, and G. C. Guidi, “Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients,” Archives of Pathology & Laboratory Medicine, vol. 133, no. 4, pp. 628–632, 2009. View at Publisher · View at Google Scholar
  41. Z.-D. Hu, Y. Chen, L. Zhang et al., “Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus,” Clinica Chimica Acta, vol. 425, pp. 202–205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. W. S. Lee and T.-Y. Kim, “Relation between red blood cell distribution width and inflammatory biomarkers in rheumatoid arthritis,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 4, pp. 505–506, 2010. View at Google Scholar · View at Scopus